120 related articles for article (PubMed ID: 35514015)
1. Development of an age- and comorbidity adjusted- optimal radiotherapy utilisation rate for women with breast cancer.
Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M
J Geriatr Oncol; 2022 Jul; 13(6):844-849. PubMed ID: 35514015
[TBL] [Abstract][Full Text] [Related]
2. Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers.
Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M
Radiother Oncol; 2023 Nov; 188():109862. PubMed ID: 37619661
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia.
Mackenzie P; Vajdic C; Delaney G; Gabriel G; Agar M; Comans T; Barton M
Tech Innov Patient Support Radiat Oncol; 2020 Dec; 16():17-23. PubMed ID: 33385070
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review.
Mackenzie P; Vajdic C; Delaney G; Comans T; Morris L; Agar M; Gabriel G; Barton M
J Geriatr Oncol; 2023 Apr; 14(3):101387. PubMed ID: 36272958
[TBL] [Abstract][Full Text] [Related]
5. Impact of radiotherapy underutilisation measured by survival shortfall, years of potential life lost and disability-adjusted life years lost in New South Wales, Australia.
Batumalai V; Shafiq J; Gabriel G; Hanna TP; Delaney GP; Barton M
Radiother Oncol; 2018 Nov; 129(2):191-195. PubMed ID: 29983259
[TBL] [Abstract][Full Text] [Related]
6. A decade of investment in radiotherapy in New South Wales: why does the gap between optimal and actual persist?
Barton MB; Delaney GP
J Med Imaging Radiat Oncol; 2011 Aug; 55(4):433-41. PubMed ID: 21843180
[TBL] [Abstract][Full Text] [Related]
7. Hospital frailty risk score is superior to legacy comorbidity indices for risk adjustment of in-hospital cirrhosis cases.
Desai AP; Parvataneni S; Knapp SM; Nephew LD; Chalasani N; Ghabril MS; Orman ES
JHEP Rep; 2024 Jan; 6(1):100955. PubMed ID: 38192536
[TBL] [Abstract][Full Text] [Related]
8. Actual Versus Optimal Radiotherapy Utilisation for Metastatic Cancer Patients in the 45 and Up Study Cohort, New South Wales.
Yap ML; O'Connell DL; Goldsbury DE; Weber MF; Barton MB
Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):650-660. PubMed ID: 33750600
[TBL] [Abstract][Full Text] [Related]
9. Provincial variations in radiotherapy utilization as a measure of access: A pan-Canadian study.
Chan J; Brown E; Dennis K; Milosevic M; Brundage M
Radiother Oncol; 2022 Feb; 167():122-126. PubMed ID: 34942281
[TBL] [Abstract][Full Text] [Related]
10. Frailty assessed by administrative tools and mortality in patients with pneumonia admitted to the hospital and ICU in Wales.
Szakmany T; Hollinghurst J; Pugh R; Akbari A; Griffiths R; Bailey R; Lyons RA
Sci Rep; 2021 Jun; 11(1):13407. PubMed ID: 34183745
[TBL] [Abstract][Full Text] [Related]
11. Does identifying frailty from ICD-10 coded data on hospital admission improve prediction of adverse outcomes in older surgical patients? A population-based study.
Harvey LA; Toson B; Norris C; Harris IA; Gandy RC; Close JJCT
Age Ageing; 2021 May; 50(3):802-808. PubMed ID: 33119731
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of measuring comorbidity indices based on clinical breast cancer records.
Eslami B; Alipour S; Seyyedsalehi MS; Nahvijou A; Omranipour R; Rajabpour MV; Zendehdel K
East Mediterr Health J; 2023 Nov; 26(11):870-876. PubMed ID: 38279882
[TBL] [Abstract][Full Text] [Related]
13. Survival Outcomes in Older Women with Oestrogen-Receptor-Positive Early-Stage Breast Cancer: Primary Endocrine Therapy vs. Surgery by Comorbidity and Frailty Levels.
Wang Y; Steinke D; Gavan SP; Chen TC; Carr MJ; Ashcroft DM; Cheung KL; Chen LC
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398140
[TBL] [Abstract][Full Text] [Related]
14. Changes to radiotherapy utilisation in Western NSW after the opening of a local service.
Butler SM
J Med Radiat Sci; 2017 Dec; 64(4):251-258. PubMed ID: 28160454
[TBL] [Abstract][Full Text] [Related]
15. Female breast cancer in New South Wales, Australia, by country of birth: implications for health-service delivery.
Roder D; Zhao GW; Challam S; Little A; Elder E; Kostadinovska G; Woodland L; Currow D
BMC Public Health; 2021 Feb; 21(1):371. PubMed ID: 33596880
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of postoperative radiation therapy for breast cancer in older women according to age and comorbidity status: An observational retrospective study in 752 patients.
Cao KI; Salviat F; Laki F; Falcou MC; Carton M; Poortmans P; Fourquet A; Kirova YM
J Geriatr Oncol; 2018 Nov; 9(6):600-605. PubMed ID: 29525744
[TBL] [Abstract][Full Text] [Related]
17. Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008.
Land LH; Dalton SO; Jensen MB; Ewertz M
Breast Cancer Res Treat; 2012 Feb; 131(3):1013-20. PubMed ID: 22002567
[TBL] [Abstract][Full Text] [Related]
18. Surgical and radiotherapy patterns of care in the management of breast cancer in NSW and ACT Australia.
Merie R; Shafiq J; Soon PS; Delaney GP
J Med Imaging Radiat Oncol; 2022 Apr; 66(3):442-454. PubMed ID: 34851031
[TBL] [Abstract][Full Text] [Related]
19. Validation of hospital frailty risk score to predict hospital use in older people: Evidence from the Australian Longitudinal Study on Women's Health.
Shebeshi DS; Dolja-Gore X; Byles J
Arch Gerontol Geriatr; 2021; 92():104282. PubMed ID: 33147534
[TBL] [Abstract][Full Text] [Related]
20. Charlson Comorbidity Index as a predictor of repeated hospital admission and mortality among older women diagnosed with cardiovascular disease.
Shebeshi DS; Dolja-Gore X; Byles J
Aging Clin Exp Res; 2021 Oct; 33(10):2873-2878. PubMed ID: 33591545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
